A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data

por McClung, Michael R., Benhamou, Claude-Laurent, Man, Zulema, Tlustochowicz, Witold, Zanchetta, Jose R., Eusebio, Rachelle, Balske, Ana M., Matzkin, Ellen, Olszynski, Wojciech P., Recker, Robert, Delmas, Pierre D.
Publicado 2012

Burden of Disease in Patients With Tumor‐Induced Osteomalacia

por Jerkovich, Fernando, Nuñez, Selva, Mocarbel, Yamile, Pignatta, Analía, Elías, Natalia, Cassinelli, Hamilton, Díaz, Adriana Graciela, Vigovich, Carlos, Balonga, María Celeste, Cohen, Ana Carolina, Mumbach, Giselle, Gonzalez, Sofía, Zanchetta, José Rubén, Zanchetta, María Belén
Publicado 2020

Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab

por Keaveny, Tony M, McClung, Michael R, Genant, Harry K, Zanchetta, Jose R, Kendler, David, Brown, Jacques P, Goemaere, Stefan, Recknor, Chris, Brandi, Maria L, Eastell, Richard, Kopperdahl, David L, Engelke, Klaus, Fuerst, Thomas, Radcliffe, Hoi-Shen, Libanati, Cesar
Publicado 2014

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

por Austin, Matthew, Yang, Yu-Ching, Vittinghoff, Eric, Adami, Silvano, Boonen, Steven, Bauer, Douglas C, Bianchi, Gerolamo, Bolognese, Michael A, Christiansen, Claus, Eastell, Richard, Grauer, Andreas, Hawkins, Federico, Kendler, David L, Oliveri, Beatriz, McClung, Michael R, Reid, Ian R, Siris, Ethel S, Zanchetta, Jose, Zerbini, Cristiano AF, Libanati, Cesar, Cummings, Steven R
Publicado 2012